Skip to main content
Equibles

AMERIPRISE FINANCIAL INC

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 820027 MINNEAPOLIS, MN
Back to AMLX Full portfolio

Position in AMLX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,253,692
-$3,814,889 QoQ
Shares Held
125,484
-75.0% QoQ
Ownership
0.113%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#75
of 207 holders
Holding Since
Mar 2022
13 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in AMLX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

AMERIPRISE FINANCIAL INC holds $802,494,373 across 36 Drug Manufacturers - Specialty & Generic names. AMLX ranks #20 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VTRS
Viatris Inc
 18,815,747 $298,794,060
2 NBIX
Neurocrine Biosciences Inc
 502,267 $84,652,078
3 LNTH
Lantheus Holdings, Inc.
 619,298 $68,704,917
4 UTHR
UNITED THERAPEUTICS Corp
 123,215 $66,761,581
5 ZTS
Zoetis Inc.
 812,181 $58,363,324
6 ELAN
Elanco Animal Health Inc
 1,396,427 $34,366,066
7 ALKS
Alkermes plc.
 630,325 $33,029,029
8 AMRX
Amneal Pharmaceuticals, Inc.
 1,581,869 $27,382,151

All Filings in AMLX

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,253,692 125,484
2025-12-31 $6,068,581 502,366
2025-09-30 $1,814,373 133,508
2025-06-30 $610,353 95,219
2025-03-31 $45,329 12,805
2024-12-31 $190,617 50,428
2023-09-30 $2,378,797 129,918
2023-06-30 $2,807,809 130,172
2023-03-31 $6,233,371 212,453
2022-12-31 $7,540,606 204,076
2022-09-30 $1,910,681 67,875
2022-06-30 $1,905,873 98,955
2022-03-31 $1,057,683 82,310